Eric Desparbes, Theravance's SVP and CFO, recently disposed of 6,033 shares of the company. The disposals took place at prices ranging from $11.85 to $11.86 per share, on dates ranging from May 20 to May 22, 2017. Desparbes still owns 350,763 shares of the company. Desparbes operates out of Brisbane, CA. Some additional info was provided as follows:
The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.
This sale was effected for tax planning purposes pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated December 15, 2016.
Includes 2,500 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on May 15, 2017.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Theravance makes a similar move, sign up!
Other recent filings from the company include the following: